BriteLife Sciences

BriteLife Sciences was a wholly owned subsidiary of Heritage Cannabis Holdings created in February 2019 to expand Heritage's presence in cannabis-based medical solutions. The subsidiary was described as focusing on proprietary medical-related cannabis products and partnerships with industry participants rather than as a standalone drug-development biotech with a disclosed clinical pipeline. Public information suggests BriteLife operated as a brand/subsidiary within Heritage's broader medical cannabis strategy, alongside Heritage's extraction and formulation capabilities. There is little evidence of an independent current operating presence, financing profile, or separate corporate footprint for BriteLife in recent years, so it appears to have been inactive or subsumed within Heritage's operations.